109 related articles for article (PubMed ID: 38742343)
21. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].
Liu J; Xu C; Yao X; Zhao R; Zhang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834
[No Abstract] [Full Text] [Related]
22. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
23. Active Surveillance of Thyroid Microcarcinomas: a Critical View.
Cernea CR; Matos LL; Eugênio C; Ferreira GM; Cerqueira YS; Leite AKN; Vanderlei FAB; de Carlucci D; Gotoda RN; Hojaij FC; Araújo-Filho VJF
Curr Oncol Rep; 2022 Jan; 24(1):69-76. PubMed ID: 35061193
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study.
Heo DB; Won HR; Tae K; Kang YE; Jeon E; Ji YB; Chang JW; Choi JY; Yu HW; Ku EJ; Lee EK; Kim M; Choe JH; Koo BS;
Surgery; 2024 Apr; 175(4):1049-1054. PubMed ID: 38281855
[TBL] [Abstract][Full Text] [Related]
25. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
26. Transglottic intralaryngeal papillary thyroid carcinoma.
Varghese BT; Nair SP; Janardhan D
Oral Oncol; 2022 Aug; 131():105935. PubMed ID: 35671688
[TBL] [Abstract][Full Text] [Related]
27. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance.
Smulever A; Pitoia F
Endocrine; 2020 Sep; 69(3):587-595. PubMed ID: 32328966
[TBL] [Abstract][Full Text] [Related]
28. Papillary microcarcinoma of the thyroid gland: current controversies and management.
Rovira A; Nixon IJ; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):110-116. PubMed ID: 30844924
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of pre-operative ultrasound and histopathology in small papillary thyroid carcinoma in the era of active surveillance.
Fung YY; Chung D; Clark JR; Low TH; Palme CE; Wykes J; Elliott MS
ANZ J Surg; 2023 Apr; 93(4):902-906. PubMed ID: 36852861
[TBL] [Abstract][Full Text] [Related]
30. Active Surveillance as First-Line Management of Papillary Microcarcinoma.
Ito Y; Miyauchi A
Annu Rev Med; 2019 Jan; 70():369-379. PubMed ID: 30230964
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.
Bayadsi H; Nylén C; Sandström M; Angelsten J; Sund M; Hennings J
Langenbecks Arch Surg; 2023 Apr; 408(1):162. PubMed ID: 37099203
[TBL] [Abstract][Full Text] [Related]
32. ASO Author Reflections: Is BRAF V600E Mutation Associated with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma?
Lai HF; Hang JF; Chen JY
Ann Surg Oncol; 2024 Jun; 31(6):3974-3975. PubMed ID: 38366182
[No Abstract] [Full Text] [Related]
33. Barriers and Facilitators to the Choice of Active Surveillance for Low-Risk Papillary Thyroid Cancer in China: A Qualitative Study Examining Patient Perspectives.
Zhu P; Zhang Q; Wu Q; Shi G; Wang W; Xu H; Zhang L; Qian M; Hegarty J
Thyroid; 2023 Jul; 33(7):826-834. PubMed ID: 36719782
[No Abstract] [Full Text] [Related]
34. Thyroid cancers in children, adolescents, and young adults with and without a history of childhood exposure to therapeutic radiation for other cancers.
Sassolas G; Hafdi-Nejjari Z; Casagranda L; Berger C; Bournaud C; Decaussin-Petrucci M; Berger N; Borson-Chazot F
Thyroid; 2013 Jul; 23(7):805-10. PubMed ID: 23286372
[TBL] [Abstract][Full Text] [Related]
35. [Locally invasive papillary thyroid cancer--our experience].
Prgomet D; Bilić M; Kovac L; Hutinec Z; Topić I
Lijec Vjesn; 2012; 134(9-10):266-70. PubMed ID: 23297510
[TBL] [Abstract][Full Text] [Related]
36. Insights into the Management of Papillary Microcarcinoma of the Thyroid.
Miyauchi A; Ito Y; Oda H
Thyroid; 2018 Jan; 28(1):23-31. PubMed ID: 28629253
[TBL] [Abstract][Full Text] [Related]
37. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
38. A rare coexistence of thyroid lymphoma with papillary thyroid carcinoma.
Cakir M; Celik E; Tuncer FB; Tekin A
Ann Afr Med; 2013; 12(3):188-90. PubMed ID: 24005594
[TBL] [Abstract][Full Text] [Related]
39. [Cystic cervical lymph node swelling - Thyroglobin-FNA allows to diagnose metastasizing papillary thyroid carcinoma].
Smaxwil C; Esianu E; Altmeier J; Zielke A
Laryngorhinootologie; 2022 Aug; 101(8):669-670. PubMed ID: 35915904
[No Abstract] [Full Text] [Related]
40. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
Zhang H; Zheng X; Liu J; Gao M; Qian B
Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
